Fred Cohen
Organization leader
Who is Fred Cohen?
Fred is a Managing Director at TPG (Texas Pacific Group) Ventures. He also retains a position as a Professor of Cellular and Molecular Pharmacology at the University of California, San Francisco. Fred also serves as a member of the boards of GenomicHealth, XDx, Kemia, Five Prime Therapeutics and Matrix Pharmaceuticals. He is also a member of the Investment Committee of the Board of Quintiles Transnational. He received his M.D. from Stanford in 1984, his D.Phil. from Oxford as a Rhodes Scholar in 1980 and his B.S. in 1978 from Yale University. Fred has been a member of the faculty of UCSF since 1986 and is best known for his work on protein structure and the conformational basis of priondisease.
We need you!
Help us build the largest biographies collection on the web!
- Also known as
- Fred Cohen, M.D., Ph.D.
- Fred E Cohen
- Education
- Doctor of Medicine, Stanford University
( - 1984) - Doctorate, University of Oxford
( - 1980) - Bachelor of Science, Yale University
( - 1978)
- Doctor of Medicine, Stanford University
- Employment
- Managing Director, TPG Capital
- Professor of Cellular and Molecular Pharmacology, University of California, San Francisco
(1986 - )
Submitted
on July 23, 2013
Citation
Use the citation below to add to a bibliography:
Style:MLAChicagoAPA
"Fred Cohen." Biographies.net. STANDS4 LLC, 2024. Web. 28 Apr. 2024. <https://www.biographies.net/biography/fred-cohen/m/02_5m7c>.
Discuss this Fred Cohen biography with the community:
Report Comment
We're doing our best to make sure our content is useful, accurate and safe.
If by any chance you spot an inappropriate comment while navigating through our website please use this form to let us know, and we'll take care of it shortly.
Attachment
You need to be logged in to favorite.
Log In